Koers Regnum Corp. Other OTC
Aandelen
RGMP
US75915R1068
Biotechnologie & Medisch Onderzoek
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 3,1 mln. 2,89 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | - 0 | Nettowinst (verlies) 2022 | - 0 | EV/omzet 2021 | - |
Nettoschuld 2021 | 22,06K 20,6K | Nettoschuld 2022 | 773K 721K | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-13
x | K/w-verhouding 2022 |
-3,97
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 1,18% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,93% | 42,68 mld. | |
-2,96% | 42,4 mld. | |
+45,32% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+8,05% | 24,94 mld. | |
-19,98% | 18,96 mld. | |
+29,52% | 12,3 mld. | |
-3,26% | 11,95 mld. | |
-2,33% | 11,55 mld. |